Richard Childs

18.0k total citations · 1 hit paper
273 papers, 10.7k citations indexed

About

Richard Childs is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Richard Childs has authored 273 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Hematology, 130 papers in Immunology and 120 papers in Oncology. Recurrent topics in Richard Childs's work include Hematopoietic Stem Cell Transplantation (125 papers), Immune Cell Function and Interaction (98 papers) and CAR-T cell therapy research (74 papers). Richard Childs is often cited by papers focused on Hematopoietic Stem Cell Transplantation (125 papers), Immune Cell Function and Interaction (98 papers) and CAR-T cell therapy research (74 papers). Richard Childs collaborates with scholars based in United States, Sweden and United Kingdom. Richard Childs's co-authors include Mattias Carlsten, Andreas Lundqvist, Susan F. Leitman, Maria Berg, A. John Barrett, A. John Barrett, Nancy F. Hensel, Roger Kurlander, Charles D. Bolan and Kairong Cui and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Richard Childs

267 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

2007 641 citations Richard Childs et al. profile →

Peers

Countries citing papers authored by Richard Childs

Since Specialization

Citations

This map shows the geographic impact of Richard Childs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Childs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Childs more than expected).

Fields of papers citing papers by Richard Childs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Childs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Childs. The network helps show where Richard Childs may publish in the future.

Co-authorship network of co-authors of Richard Childs

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Childs. A scholar is included among the top collaborators of Richard Childs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Childs. Richard Childs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	REMOVED: Interim Results of a Phase II Trial of Omidubicel, Ex-Vivo Expanded Umbilical Cord Blood Transplantation in Patients with Treatment-Refractory Severe Aplastic Anemia 2025 ·Transplantation and Cellular Therapy ·Richard Childs, Xin Tian, Georg Aue, Neal S. Young, Raquel Ríos, Jian Hur, Jennifer Wilder, Kristen Cole, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Robert Reger	2
2	SARS-CoV-2 Immune Complex–Mediated Neutrophil Activation 2025 ·Open Forum Infectious Diseases ·(unknown), (unknown), Heather Teague, Marcos J. Ramos-Benítez, (unknown), Xin Tian, Robert Reger, Peter D. Burbelo, (unknown), Yogendra Kanthi, Jeffrey I. Cohen, (unknown), Anthony F. Suffredini, Christopher S. King, Steven D. Nathan, Richard Childs, Daniel S. Chertow, Jeffrey R. Strich	2
3	Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cells 2025 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Abeda Mulla, David Allan, Brynn B. Duncan, (unknown), So Gun Hong, Rafet Başar, Katayoun Rezvani, Richard Childs, Chuanfeng Wu, Cynthia E. Dunbar	0
4	Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology 2024 ·Frontiers in Cellular and Infection Microbiology ·Elena Cherkasova, Long Chen, Richard Childs	7
5	Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor–natural killer cells 2022 ·Cytotherapy ·Mark E. Gurney, (unknown), Sarah Corcoran, Sarah Brophy, Janusz Krawczyk, Neil Otto, David Hermanson, Richard Childs, Éva Szegezdi, Michael O’Dwyer	22
6	Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia 2022 ·Leukemia ·Emma M. Groarke, Bhavisha A. Patel, Ruba Shalhoub, Fernanda Gutierrez‐Rodrigues, Parth Desai, Harshraj Leuva, Yoshitaka Zaimoku, (unknown), (unknown), Jennifer Lotter, Olga Rios, Richard Childs, David J. Young, Alina Dulau‐Florea, Cynthia E. Dunbar, Katherine R. Calvo, Colin O. Wu, Neal S. Young	28
7	Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome 2021 ·British Journal of Haematology ·Richard Childs, Xin Tian, (unknown), Enkhtsetseg Purev, Ritesh R. Kotecha, Mattias Carlsten, Joseph Clara, Willy A. Flegel, Sharon Adams, Hanh Khuu, David F. Stroncek, Lisa Cook, Tatyana Worthy, Nancy L. Geller, (unknown), Jennifer Wilder, Robert Reger, Georg Aue	4
8	In Vivo Tracking of Adoptively Transferred Natural Killer Cells in Rhesus Macaques Using 89Zirconium-Oxine Cell Labeling and PET Imaging 2020 ·Clinical Cancer Research ·Noriko Sato, Kate Stringaris, Jan Davidson‐Moncada, Robert Reger, Stephen Adler, Cynthia E. Dunbar, Peter L. Choyke, Richard Childs	51
9	A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo‐immunized patients 2020 ·British Journal of Haematology ·(unknown), Enkhtsetseg Purev, Kamille A. West, (unknown), Tatyana Worthy, Lisa Cook, (unknown), (unknown), (unknown), Willy A. Flegel, Sharon Adams, Robert Reger, Georg Aue, Xin Tian, Richard Childs	17
10	Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets 2018 ·Science Immunology ·Chuanfeng Wu, Diego A. Espinoza, Samson Koelle, Di Yang, (unknown), Heinrich Schlums, Bernard A. P. Lafont, Jan Davidson‐Moncada, Rong Lu, Amitinder Kaur, Quirin Hammer, Brian Li, Sandhya R. Panch, David Allan, Robert E. Donahue, Richard Childs, Chiara Romagnani, Yenan T. Bryceson, Cynthia E. Dunbar	36
11	Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms 2017 ·Clinical Cancer Research ·Jong Bok Lee, Mark D. Minden, Weihsu C. Chen, (unknown), Branson Chen, Hyeonjeong Kang, Andrea Arruda, Dalam Ly, Sandy D. Der, Sohyeong Kang, (unknown), Cheryl D’Souza, Yueyang Li, Richard Childs, John E. Dick, Li Zhang	80
12	High-Efficiency Lentiviral Genetic Modification of Primary Human Natural Killer Cells 2017 ·Blood ·(unknown), David Allan, (unknown), Mala Chakraborty, Emily R. Levy, (unknown), Long Chen, (unknown), Georg Aue, Kate Stringaris, Robert Reger, Richard Childs	2
13	Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer 2016 ·Cancer Research ·Elena Cherkasova, (unknown), (unknown), (unknown), Yoshiyuki Takahashi, Nanae Harashima, Hisayuki Yokoyama, Ramaprasad Srinivasan, W. Marston Linehan, Michael I. Lerman, Richard Childs	92
14	Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma 2016 ·Clinical Cancer Research ·Mattias Carlsten, Neha Korde, Ritesh R. Kotecha, Robert Reger, (unknown), Dickran Kazandjian, Ola Landgren, Richard Childs	134
15	Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma 2016 ·OncoImmunology ·Markus Granzin, Ana Stojanovic, Matthias Miller, Richard Childs, Volker Huppert, Adelheid Cerwenka	70
16	Inactivation of the von Hippel–Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer 2011 ·Oncogene ·Elena Cherkasova, (unknown), Sambasiva P. Rao, Yoshiyuki Takahashi, В. Н. Сенченко, Anna V. Kudryavtseva, Michael L. Nickerson, Maria J. Merino, Julie A. Hong, David S. Schrump, Ram Srinivasan, W. Marston Linehan, Xin Tian, Michael I. Lerman, Richard Childs	56
17	Bench to bedside: development and implementation of a clinical protocol for the early molecular detection for the improved diagnosis of invasive pulmonary aspergillosis and zygomycosis 2009 ·Mycoses ·T. J. Walsh, Vasilios Pyrgos, Masashi Kasai, (unknown), William Hope, (unknown), Rūta Petraitienė, Vidmantas Petraitis, Lindsey A. Greene, (unknown), (unknown), (unknown), Juan Gea‐Banacloche, Steven M. Holland, Harry L. Malech, Richard Childs, Gary A. Fahle, (unknown), Yat Fung Shea, (unknown)	1
18	Cutting Edge: Bortezomib-Treated Tumors Sensitized to NK Cell Apoptosis Paradoxically Acquire Resistance to Antigen-Specific T Cells 2009 ·The Journal of Immunology ·Andreas Lundqvist, Su Su, Sheila Rao, Richard Childs	24
19	The human endogenous retrovirus (HERV) derived kidney Cancer antigen CT-RCC1 induces proliferation of CD8+ antigen-specific T-cells in vitro that kill renal cell carcinoma (RCC) and is up-regulated by inhibiting histone deacetylase 2008 ·Cancer Research ·Sheila Rao, Abdul Tawab, Roger Kurlander, Nanae Harashima, Andreas Lundqvist, Julie A. Hong, (unknown), (unknown), Elena Cherkasova, Philip McCoy, David S. Schrump, Richard Childs	2
20	The Benefits of an Alloresponse: Graft-Versus-Tumor 2000 ·Journal of Hematotherapy & Stem Cell Research ·J. Carl Barrett, Richard Childs	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact